Endogenous human microRNAs that suppress breast cancer metastasis.

Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Nature (Impact Factor: 42.35). 02/2008; 451(7175):147-52. DOI: 10.1038/nature06487
Source: PubMed

ABSTRACT A search for general regulators of cancer metastasis has yielded a set of microRNAs for which expression is specifically lost as human breast cancer cells develop metastatic potential. Here we show that restoring the expression of these microRNAs in malignant cells suppresses lung and bone metastasis by human cancer cells in vivo. Of these microRNAs, miR-126 restoration reduces overall tumour growth and proliferation, whereas miR-335 inhibits metastatic cell invasion. miR-335 regulates a set of genes whose collective expression in a large cohort of human tumours is associated with risk of distal metastasis. miR-335 suppresses metastasis and migration through targeting of the progenitor cell transcription factor SOX4 and extracellular matrix component tenascin C. Expression of miR-126 and miR-335 is lost in the majority of primary breast tumours from patients who relapse, and the loss of expression of either microRNA is associated with poor distal metastasis-free survival. miR-335 and miR-126 are thus identified as metastasis suppressor microRNAs in human breast cancer.

Download full-text


Available from: Thordur Oskarsson, Mar 14, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: MicroRNAs (miRNA) - a novel class of small noncoding RNAs genes. Their final product is a twenty two nucleotides functional molecule of RNA. These small non-coding RNAs silence and target several genes through varied signalling pathways that include important physiological networks. MiRNAs regulates post-transcriptional expression of genes. The miRNA was discovered as small temporal RNA (stRNA) regulating development transition in Caenorhabditis elegans. The miRNAs have an enthusiastic part in neoplastic transformations either by elevating expression of oncogenes or reducing tumours suppressor genes and oncogene. Although miRNAs are key gene regulators, yet experimental and computational approaches are still scanty. Complete understanding of this prime regulating transcript class is still in need of exuberated research. The current article is reviewing miRNA, its discovery, role of miRNAs in suppression of tumours and oncogenes and role of miRNA in diagnosing cancer and its therapy.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Traditional breast cancer (BrCa) bone metastasis models contain many limitations with regards to controllability, reproducibility, and flexibility of design. In this study, a novel biomimetic bone microenvironment was created by integrating hydroxyapatite (HA) and native bioactive factors deposited by osteogenic induction of human bone marrow mesenchymal stem cells (MSCs) within a cytocompatible chitosan hydrogel. It was found that a 10% nanocrystalline HA (nHA) chitosan scaffold exhibited the highest BrCa adhesion and proliferation when compared to chitosan scaffolds with 20% nHA, 10% and 20% microcrystalline HA as well as amorphous HA. This 3D tunable bone scaffold can provide a biologically relevant environment, increase cell-cell and cell-matrix interactions as found in native bone, and retain the behavior of BrCa cells with different metastasis potential (i.e., highly metastatic MDA-MB-231, less metastatic MCF-7 and transfected MDA-MB-231). The co-culture of MSCs and MDA-MB-231 in this bone model illustrated that MSCs have the capacity to upregulate the expression of the well-known metastasis-associated gene metadherin within BrCa cells. In summary, this study illustrates the capacity of our 3D bone model in creating a biomimetic environment conducive to recapitulating the behavior of metastatic BrCa cells, making it a promising tool for in vitro BrCa cell bone metastasis study and potential therapeutics discovery. Copyright © 2014. Published by Elsevier Ltd.
    Acta Biomaterialia 12/2014; 14. DOI:10.1016/j.actbio.2014.12.008 · 5.68 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mesenchymal stem/stromal cells (MSCs) are progenitor cells shown to participate in breast tumor stroma formation and to promote metastasis. Despite expanding knowledge of their contributions to breast malignancy, the underlying molecular responses of breast cancer cells (BCCs) to MSC influences remain incompletely understood. Here, we show that MSCs cause aberrant expression of microRNAs, which, led by microRNA-199a, provide BCCs with enhanced cancer stem cell (CSC) properties. We demonstrate that such MSC-deregulated microRNAs constitute a network that converges on and represses the expression of FOXP2, a forkhead transcription factor tightly associated with speech and language development. FOXP2 knockdown in BCCs was sufficient in promoting CSC propagation, tumor initiation, and metastasis. Importantly, elevated microRNA-199a and depressed FOXP2 expression levels are prominent features of malignant clinical breast cancer and are associated significantly with poor survival. Our results identify molecular determinants of cancer progression of potential utility in the prognosis and therapy of breast cancer. Copyright © 2014 Elsevier Inc. All rights reserved.
    Cell Stem Cell 12/2014; 15(6):762-774. DOI:10.1016/j.stem.2014.10.001 · 22.15 Impact Factor